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Introduction
Genomic syndromes are alterations to a suite of contigu-
ous genes, such as deletions, duplications, or aneuploi-
dies, that result in characteristic sets of phenotypic
changes, some of which may require medical interven-
tions (e.g. Feinstein and Singh 2007). Such syndromes
provide unique insights into human evolution because
they represent naturally occurring genomic variation that
can be linked with speciﬁc phenotypic consequences for
human growth, development and cognition. For example,
Haig and Wharton (2003), Oliver et al. (2007) and Crespi
and Badcock (2008) show how the phenotypes of Prader-
Willi and Angelman syndromes, which are due to diamet-
ric alterations of a region of chromosome 15 bearing a
cluster of imprinted genes, provide insight into the evolu-
tion of human childhood and mother–offspring interac-
tions mediated by imprinting effects. Similarly, Williams
syndrome, caused by deletions of a region of chromo-
some 7, involves an unusual cognitive proﬁle of spared or
enhanced expressive-language skills, but greatly impaired
visual-spatial abilities, which has been interpreted as pro-
viding insights into the genetic and neurological architec-
ture of human language (Tassabehji 2003; Meyer-
Lindenberg et al. 2006; Brock 2007). Duplications of the
Williams-syndrome region, by contrast, involve high rates
of autism, with expressive language abilities selectively
impaired (Berg et al. 2007).
Several genomic syndromes involve gains or loss of
entire chromosomes. Loss of part or all of an X chromo-
some causes Turner syndrome in females, whereas gains
of one or more X chromosomes result in Klinefelter syn-
drome in males (Simpson et al. 2003; Bondy 2006). These
syndromes are of particular interest in human evolution
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Abstract
Turner syndrome is caused by loss of all or part of an X chromosome in
females. A series of recent studies has characterized phenotypic differences
between Turner females retaining the intact maternally inherited versus pater-
nally inherited X chromosome, which have been interpreted as evidence for
effects of X-linked imprinted genes. In this study I demonstrate that the differ-
ences between Turner females with a maternal X and a paternal X broadly
parallel the differences between males and normal females for a large suite
of traits, including lipid proﬁle and visceral fat, response to growth hormone,
sensorineural hearing loss, congenital heart and kidney malformations, neuro-
anatomy (sizes of the cerebellum, hippocampus, caudate nuclei and superior
temporal gyrus), and aspects of cognition. This pattern indicates that diverse
aspects of human sex differences are mediated in part by X-linked genes, via
genomic imprinting of such genes, higher rates of mosaicism in Turner females
with an intact X chromosome of paternal origin, karyotypic differences
between Turner females with a maternal versus paternal X chromosome, or
some combination of these phenomena. Determining the relative contributions
of genomic imprinting, karyotype and mosaicism to variation in Turner syn-
drome phenotypes has important implications for both clinical treatment of
individuals with this syndrome, and hypotheses for the evolution and develop-
ment of human sexual dimorphism.
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bears a concentration of genes related to reproduction
and cognition (Vallender and Lahn 2004; Nielsen et al.
2005). Phenotypes related to reproduction and cognition
are indeed notably altered in Turner and Klinefelter syn-
dromes, with both syndromes involving dysregulation of
gonadal development and alterations to neurocognitive
proﬁles of verbal versus visual-spatial skills (Money 1993;
Simpson et al. 2003; Bondy 2006; Kesler 2007). These
ﬁndings indicate that studies of Turner and Klinefelter
syndromes that integrate approaches from evolutionary
biology and medical genetics should provide useful
insights into both the developmental-genomic aetiologies
of these conditions, and how X-linked genes have been
involved in the evolution of modern humans.
In this paper I focus on the causes of phenotypic varia-
tion among individuals with Turner syndrome, and
between Turner syndrome females, normal females and
normal males. Turner syndrome is characterized pheno-
typically by short stature, gonadal dysgenesis, a range of
anatomical stigmata, and a neurocognitive proﬁle of
spared or enhanced verbal abilities but impaired visual-
spatial and social skills (Sybert and McCauley 2004;
Bondy 2006; Kesler 2007). The syndrome is caused by
partial or complete loss of one of the two X chromo-
somes in most or all cells, due to a range of cytogenetic
alterations, with most cases associated with either: (i) the
absence of one entire X (45,X), resulting in monosomy,
(ii) deletion of part of the short, Xp, arm of the X chro-
mosome (46,XdelXp), or (iii) formation of an Xq iso-
chromosome (46,XiXq, with two identical arms of Xq
and an Xp deletion) (see Bondy 2006 for more detail on
karyotypic variation).
Turner females may also be mosaics of 45,X with
46,XX cells, or mosaics of 45,X cells with cells bearing
46,XdelXp, 46,XiXq, 46,XY, or other karyotypes. Esti-
mates of the frequency of mosaicism range from 67%
to 90% (Held et al. 1992; Ferna ´ndez-Garcı ´a et al. 2000),
but the presence and degree of mosaicism has been dif-
ﬁcult to establish because multiple tissues must be stud-
ied and PCR-based methods must be used for accurate
quantiﬁcation, but most studies have relied on karyo-
type data from single tissues (Ferna ´ndez-Garcı ´a et al.
2000). Chromosomal mosaicism of the forms 45,X with
46,XX, or 45,X with 46,XdelXp or 46,XiXq, notably mit-
igates the severity of Turner syndrome phenotypes (e.g.
Murphy et al. 1997; El-Mansoury et al. 2007). Turner
phenotypes are also mediated in part by preferential
inactivation of structurally abnormal X chromosomes,
or in some cases by failed or partial X-inactivation
(Migeon et al. 1996; Wolff et al. 2000; Leppig and
Disteche 2001).
Determining the nature and causes of karyotype–pheno-
type correlations in Turner syndrome is important both for
clinical treatment of this condition, and for understanding
the roles of sex-linked genes in human evolution and devel-
opment. The primary genetic consequences of Turner syn-
drome aneuploidies, deletions and mosaicism, that may
contribute to phenotypic variation between Turner syn-
drome females and 46,XX females, and among females with
this syndrome, are twofold: (i) full or partial haploinsufﬁ-
ciency of noninactivated X-linked genes in pseudoautoso-
mal region 1 (at the terminus of the Xp arm) or elsewhere
on this chromosome; and (ii) the presence of a full or frag-
mentary Y chromosomal in some or all cells (Bondy 2006;
Lynn and Davies 2007).
A third source of potential variation in Turner syn-
drome phenotypes is epigenetic. Given that the intact
chromosome in Turner syndrome is inherited from either
the father or the mother, imprinting (silencing by parent
of origin) of genes may also inﬂuence gene expression on
the X (Skuse et al. 1997; Skuse 1999, 2000, 2005, 2006;
Davies et al. 2006), as it does for many autosomal
imprinted genes. A series of studies has tested for pheno-
typic differences between Turner females with the intact
X inherited either maternally or paternally (Hamelin et al.
2006; Bondy et al. 2007; Sagi et al. 2007). Some of these
studies have employed small sample sizes, but more-
recent and larger studies have demonstrated statistically
signiﬁcant differences for diverse traits, with important
implications for genetic diagnosis and clinical treatment.
Skuse (1999) has suggested that X-linked imprinting
may serve as a mechanism for the evolution of sexual
dimorphism in humans, given that gene dosages of
X-linked imprinted genes are expected to differ between
the sexes, and a basis in population-genetic theory has
been provided for this hypothesis by Iwasa and Pomian-
kowski (1999) and Mills and Moore (2006). In accor-
dance with these ideas, Skuse et al. (1997) has shown that
Turner-syndrome individuals with the maternally inher-
ited X intact (the only X present in normal XY males)
differ from paternal-X females in exhibiting a set of rela-
tively male-typical cognitive traits including higher liabil-
ity to autism.
Do other traits exhibit a similar pattern, of normal sex
differences mirroring differences between Turner females
with an intact maternal X (Xmat) versus an intact pater-
nal X (Xpat)? If so, can these differences be ascribed to
effects of X-linked imprinting, or to correlates of the
parental origin of the X chromosome such as mosaicism
or karyotype, given that dosages of noninactivated
X-linked genes may also mediate human sexual dimor-
phism? Sufﬁcient data are available to evaluate these
patterns for seven categories of phenotype.
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females with Turner syndrome
In comparing the results from multiple studies that assess
the same phenotypic trait in Turner syndrome females
with an intact maternal versus paternal X chromosome
(Table 1), it is important to recognize that the different
studies have used different clinical populations; for exam-
ple, Tsezou et al. (1999) and Bondy et al. (2007) included
45X/46,XX mosaics, whereas Hamelin et al. (2006) and
Sagi et al. (2007) excluded them, and Sagi et al. (2007)
included only females with 45,X or isodicentric karyo-
types. This source of among-study variation, in conjunc-
tion with variation between and within studies in sample
sizes and methods of quantifying phenotypes (e.g. Sagi
et al. 2007), means that it is difﬁcult to interpret failures
of replication in terms of the presence or absence of bio-
logical effects. For each trait, data are compiled on pat-
terns of concordance between differences between Xmat
versus Xpat Turner females, differences between 45,X and
other Turner females, and differences between males and
females in normal populations (Table 1).
Response to growth hormone
Females with Turner syndrome exhibit reduced adult stat-
ure that can be prevented in part via treatment with
growth hormone (Sybert and McCauley 2004; Bondy
2006). Tsezou et al. (1999) found no signiﬁcant difference
between Xmat and Xpat Turner females in growth-hor-
mone-stimulated height gain over 2 years, but Hamelin
et al. (2006) reported signiﬁcantly greater gain in height
among Xmat than Xpat Turner females, over 5–6 years
between ages 10 and 20, with parental origin explaining
36–53% of the response to growth hormone. Sagi et al.
(2007) found a mean height gain per year in response to
growth hormone treatment that was 28% greater in Xmat
than Xpat females, but this difference was not statistically
signiﬁcant. Males are substantially and signiﬁcantly more
responsive to growth hormone treatment than females
(Burman et al. 1997; Thangavel and Shapiro 2007).
Lipid proﬁles and visceral fat
Turner syndrome females exhibit an atherogenic lipid
proﬁle (a distribution of serum fatty acid levels associ-
ated with high risk of atherosclerosis) and high levels of
visceral fat compared to normal 46,XX females (Van
et al. 2006a). Van et al. (2006b) reported signiﬁcantly
higher levels of visceral fat, and higher levels of total
cholesterol, LDL cholesterol, and triglycerides, in Xmat
than Xpat Turner females aged 27–31 years on average,
and they note that this difference directly parallels the
difference between normal males and females. By con-
trast, in a population of Turner females with a mean
age of 15 years, Sagi et al. (2007) found lower total and
low-density lipoprotein levels in the Xmat than Xpat
group.
Among normal middle-aged populations, males exhibit
higher levels of visceral fat, and higher LDL levels, than
do females (Freedman et al. 2004; Van et al. 2006a,b).
However, such sex differences in LDL levels are absent or
much less pronounced in children and adolescents
(Freedman et al. 2000; Jolliffe and Janssen 2006).
Compared to 45,X/46,XX mosaics, levels of LDL, trigly-
cerides, and body fat were higher in 45,X females by 10%,
26% and 18% respectively in the study of El-Mansoury
et al. (2007), but these differences were not statistically
signiﬁcant. By contrast, levels of total cholesterol were sig-
niﬁcantly higher in 45,X than 45,X/46,XX mosaics, by
15% (P < 0.01 in El-Mansoury et al. 2007). This popula-
tion exhibited a mean age of 31, comparable with that of
Van et al. (2006b).
Sensorineural hearing loss
Turner syndrome females exhibit high rates of early-
onset hearing loss, due to otitis media (middle-ear infec-
tions), auricular anomalies, and other causes (King et al.
2007), with symptoms notably more severe in cases with
monosomy 45,X than in cases with mosaicism or struc-
tural X-chromosome defects (Barrena ¨s et al. 1999, 2000;
Morimoto et al. 2006). Otitis media and aging-related
hearing loss are also more common and severe in males
than 46,XX females (see Barrena ¨s et al. 2000; Henry
2004), but early-onset hearing loss is very rare in such
populations. In mouse models of hearing loss, females
lose hearing earlier than males in a strain with early-
onset hearing loss comparable in timing to that in
Turner syndrome females, but males lose hearing earlier
in strains with the late-onset, age-related loss that corre-
sponds to the usual situation in humans (Henry 2004).
These ﬁndings suggest that early-onset and late-onset
hearing loss involve different mechanisms, that are med-
iated differently by sex.
Hamelin et al. (2006) found signiﬁcantly less early-
onset sensorineural hearing loss among Xmat (34% of
patients) than Xpat (67%) females with Turner syndrome.
This difference corresponds to the sex difference between
normal male and female humans to the extent that mech-
anisms of early hearing loss are similar between females
with Turner syndrome and mouse strains with early-onset
hearing loss. El-Mansoury et al. (2007) reported a 51%
incidence of impaired hearing in 45,X Turner females,
compared to 26% in 45,X/46,XX mosaic females
(P = 0.07).
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with the differences between normal males and females, and the differences between monosomic 45,X Turner females versus Turner females
with other karyotypes. These parallel patterns may be caused by X-linked imprinting mediating the development of sexual dimorphism, by lower
levels of mosaicism and higher rates of 45,X monosomy in Turner females with a maternal X chromosome, or by both processes (See text for
details).
Trait Xmat/Xpat difference Sex difference 45,X/other difference Comments
Response
to growth
hormone
Greater response in Xmat
females (1) or no
difference (2,3)
Males show larger
response than females
(4,5)
No data Height in Turner
syndrome affected by
X-linked and autosomal
genes (6)
Lipid proﬁle and
visceral fat
Higher cholesterol, LDL, and
visceral fat in Xmat females,
in middle age (7); lower
total and LDL LDL cholesterol
in Xmat females in
adolescence (3)
Males have higher LDL
and visceral fat than
females across middle
age; sexes similar in
adolescence (7–11)
45,X females have higher
cholesterol than 45,X/
46,XX females (12)
In (7), females were age
27–31 on average; in
(3), they were age 15
on average
Sensorineural
hearing loss
Xmat females show lower
levels of early-onset hearing
loss (1)
Males show more overall
hearing loss is rare (13,14);
in mouse models, males
have less early-onset
hearing loss (14)
45,X females may have
more hearing loss than
45,X/46,XX females
(P = 0.07) (12)
Congenital heart
defects
Xmat females exhibit more
cardiac anomalies (15), or
no difference (2,3,6)
Higher rates of aortic
cardiac anomalies at
birth in males (16,17)
Higher rates of aortic
cardiac anomalies in
45,X than mosaic
females (18,19)
Turner syndrome cardiac
defects are found
differentially in males
(16–21).
Congenital kidney
defects
Xmat females have higher
rate of renal anomalies (3),
or no difference (6)
Higher rates of renal
anomalies at birth in
males (16) or no
difference (17)
No difference in rates of
‘urinary track
malformations’ between
45,X and 45,X/46,XX
females (12)
Neuroanatomy Larger cerebellum in Xmat
than 46,XX females (22);
larger superior temporal
gyrus in Xmat than Xpat
females (23); larger
hippocampus and smaller
caudate nuclei in Xmat
than Xpat females (24); or
no differences (25,26)
Males have larger
cerebellum, larger left
anterior superior
temporal gyrus, and
larger amygdala-
hippocampus, but
smaller caudate nuclei
(27–29)
45X/46,XX females
exhibit intermediacy
between 45,X and
46,XX females for some
neuroanatomical and
neurological-function
traits (30–32)
Psychological
traits
Xmat females show
impaired social cognition,
lower verbal skills, more
attention, thought and
aggression problems,
higher rate of autism
(33–35); Xmat females
have better visual-spatial
memory (35); twofold
higher rate of ADHD in Xmat
females but difference
not signiﬁcant (36)
Males exhibit poorer
social and verbal skills
than females, higher
rates of autism and
ADHD, and better
visual-spatial skills
(37–39)
Larger difference
between high verbal
and low performance
skills in 45,X than 45,X/
46,XX females (40)
(1) Hamelin et al. 2006 (2) Tsezou et al. 1999 (3) Sagi et al. 2007 (4) Burman et al. 1997 (5) Thangavel and Shapiro 2007; (6) Bondy et al. 2007
(7) Van et al. 2006b (8) Van et al. 2006a (9) Freedman et al. 2000 (10) Freedman et al. 2000 (11) Jolliffe and Janssen 2006 (12) El-Mansoury
et al. 2007 (13) Barrena ¨s et al. 2000 (14) Henry 2004 (15) Chu et al. 1994 (16) Lary and Paulozzi 2001 (17) Shaw et al. 2003 (18) Gøtzsche et al.
1994 (19) Prandstraller et al. 1999 (20) Geodakian and Sherman 1970 (21) Geodakian and Sherman 1971 (22) Brown et al. 2002 (23) Kesler et al.
2003 (24) Cutter et al. 2006 (25) Good et al. 2003 (26) Kesler et al. 2004 (27) Good et al. 2001 (28) Chen et al. 2007 (29) Wilke et al. 2007 (30)
Murphy et al. 1997 (31) Murphy et al. 1993 (32) Murphy et al. 1994 (33) Skuse et al. 1997 (34) Skuse 1999 (35) Bishop et al. 2000 (36) Russell
et al. 2006 (37) Geary 1998 (38) Baron-Cohen 2003 (39) Hermens et al. 2005 (40) Temple and Carney 1993.
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Chu et al. (1994) reported a signiﬁcantly higher inci-
dence of cardiac anomalies in Turner females with an
intact Xmat (34, 38% of 90) than an intact Xpat
(4, 11% of 34, Fisher’s exact test, P = 0.0026), based on
pooling of published data from four studies that indi-
vidually yielded Fisher’s exact values of 0.005 (Ross et al.
1991), 0.088 (Lorda-Sanchez et al. 1992), 0.15 (Chu
et al. 1994) and 0.70 (Mathur et al. 1991). By contrast,
three other studies have reported similar rates of cardiac
anomalies between groups (Tsezou et al. 1999; Bondy
et al. 2007; Sagi et al. 2007). Overall, using Fisher’s com-
bining test of probabilities, the difference between these
two groups was not signiﬁcant (v
2 = 20.3, 14 d.f.,
P = 0.13). Differences between studies may be due to
the sensitivity of diagnostic methods (Bondy et al.
2007), and variation in the karyotypes present or the
degrees of mosaicism, given substantially higher rates of
cardiac anomalies in monosomic 45,X females than
mosaic females (Gøtzsche et al. 1994; Prandstraller et al.
1999; El-Mansoury et al. 2007).
The cardiac defects most common in Turner syndrome
include anomalies of the aorta, especially aortic coarcta-
tion and stenosis. These heart defects exhibit 20–50%
higher rates in males (Geodakian and Sherman 1971; Lary
and Paulozzi 2001; Shaw et al. 2003), and they have been
considered as the most well-deﬁned ‘male’ heart defects
(Geodakian and Sherman 1970, 1971).
Congenital kidney defects
Sagi et al. (2007) found a higher incidence of renal anom-
alies in Xmat Turner females (12/60) than in Xpat
females (0/20; P = 0.03, Fisher’s exact test). By contrast, a
recent analysis with large samples sizes found no such dif-
ference (33/133 vs 12/50 respectively, P > 0.50) (Bondy
et al. 2007), as did earlier studies with small samples
(reviewed in Sagi et al. 2007), including Chu et al.
(1994). Fisher’s combining test of the data from the seven
studies to date showed a lack of overall signiﬁcance
(P > 0.50). Congenital renal anomalies show a lack of sex
bias (ratio 1:1) in one epidemiological study (Shaw et al.
2003), but a signiﬁcant male bias (1.74:1) in another
study (Lary and Paulozzi 2001).
Neuroanatomy
For each of the three studies showing X-chromosome
parent of origin effects on neuroanatomy in Turner syn-
drome (Brown et al. 2002; Kesler et al. 2003; Cutter et al.
2006), the observed parental-origin differences parallel the
differences between males and 46,XX females (Good et al.
2001; Chen et al. 2007; Wilke et al. 2007), given the
information available (Table 1).
Psychological traits
Skuse et al. (1997) and Skuse (1999) reported that Xmat
females exhibited higher levels of verbal, social, emotional
and behavioural problems than Xpat females (Table 1);
by contrast, Bishop et al. (2000) describe evidence that
Xmat Turner females exhibit better visual-spatial mem-
ory, but worse verbal memory, than Xpat females, with
females also better than males at this verbal-memory task.
Russell et al. (2006) found that seven (35%) of 20 Xmat
Turner females, and one (14%) of seven Xpat females
were diagnosed with ADHD, but this difference was not
statistically signiﬁcant (Fisher’s exact, P = 0.30), nor was
the difference signiﬁcant between 45,X females (8, 30% of
27) and mosaic females (4, 17% of 23) (Fisher’s exact
test, P = 0.25). Similarly, Sagi et al. (2007) reported that
ﬁve of seven Xpat females, but only four of eleven Xmat
females, had academic skills or degrees (Fisher’s exact test,
P = 0.17).
The verbal versus visual-spatial differences between
Turner syndrome females and 46,XX females contrast
with the differences between males and 46,XX females,
given that on average, males exhibit relatively better
visual-spatial skills compared to verbal skills than do
females (Geary 1998; Baron-Cohen 2003). However, as
described by Skuse et al. (1997) and Skuse (1999), some
of the neurocognitive differences between Xmat and Xpat
Turner females, such as lower verbal, attentional,
emotional and social skills in the Xmat genotype, notably
parallel the differences between males and 46,XX females.
The effects of karyotype and mosaicism on cognitive
functions in Turner syndrome have yet to be investigated
in detail, but Temple and Carney (1993) reported that
the differences between verbal IQ scores and performance
IQ scores were larger in monosomic 45,X than in mosaic
45,X/46,XX Turner females, and Murphy et al. (1993,
1994, 1997) describes evidence from neuroimaging and
cognitive studies for X-chromosome dosage effects on
verbal versus visual-spatial/performance skills. Genetic
evidence for such effects has been provided by Vawter
et al. (2007), who found strong correlations of gene-
expression levels with verbal skills, for several X-linked
genes, in individuals with Klinefelter syndrome (usually
XXY in males).
Pleiotropic effects of growth
Of the traits in Table 1 that show evidence of differences
between Xmat and Xpat Turner females, one trait,
response to growth hormone, is a direct correlate of
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neural hearing loss, lipid proﬁle and body composition,
and neuroanatomy, are also known to be growth-related.
Thus, in females with Turner syndrome females, the
extent of hearing loss is positively associated with reduced
height (and lower IGF1 levels) (Barrena ¨s et al. 2000; Mor-
imoto et al. 2006), and growth hormone treatment is
associated with both reduced truncal (visceral) obesity
(Gravholt et al. 2005) and increased levels of grey matter
in the temporal, parietal and occipital lobes of the brain
(Cutter et al. 2006). Taller females with Turner syndrome
also bear a reduced number of anatomical stigmata
(El-Mansoury et al. 2007), but there is no apparent effect
of GH treatment or height on cognitive function in
Turner syndrome (Ross 2005; Messina et al. 2007).
Barrena ¨s et al. (2000) describe evidence that growth-
related phenotypes in Turner syndrome (and other aneu-
ploidies) are mediated by effects of aneuploidy on rates of
cell turnover, which in Turner syndrome differentially
modulate growth of SHOX-regulated mesodermal tissues
with the shortest cell cycle time and highest cell cycle rate.
This hypothesis of aneuploidy effects on cell cycle times is
also supported by evidence for altered temporal control
of cell replication in Turner syndrome (Reish et al. 2002),
and changes in the proportions of 45,X vs 46,XX cell lines
over time in vivo (Nielsen 1976; Held et al. 1992; Devi
et al. 1998).
Despite patterns in covariation of clinical phenotype
with height in Turner syndrome, Turner females clearly
do not differ in height by parental origin of the X chro-
mosome (Mathur et al. 1991; Bondy et al. 2007; Kochi
et al. 2007; Sagi et al. 2007). Instead, the height of Turner
syndrome females shows a strong, positive, highly signiﬁ-
cant correlation with their mother’s height (regardless of
parental origin of the X), but the association with father’s
height is smaller or nonexistent (Salerno and Job 1987;
Chu et al. 1994; Tsezou et al. 1999; Hamelin et al. 2006;
Bondy et al. 2007; Kochi et al. 2007). The simplest expla-
nation for this remarkable, well-replicated ﬁnding is that
haploinsufﬁciency of some X-linked, noninactivated gene
or genes (such as SHOX) results in altered transactivation
of one or more autosomal imprinted genes that regulate
growth. The imprinted gene DLK1 represents a notable
functional and positional candidate for such effects due
to its roles in regulating growth, adiposity, and bone
development (Abdallah et al. 2004, 2007; Ansell et al.
2007), its location at 14q32.2 where apparent imprinting
effects on human height have been described (Mukhopad-
hyay and Weeks 2003), and the phenotypic effects of
reduced or absent DLK1 expression, which include low
birth weight, short stature, high palate, micrognathia
(small teeth), small hands, hypotonia (weak muscle tone),
scoliosis, recurrent otitis media, high cholesterol and
obesity (Kotzot 2004; Temple et al. 2007), all of which
are relatively common in Turner syndrome. Comparable
interactions between X-linked genes and autosomal
imprinted genes affecting growth have been described in
mice (Vrana et al. 2000; Loschiavo et al. 2007), and Pan
et al. (2007) describe sex-speciﬁc X-chromosome effects
on height and triglyceride levels that are consistent with
an important role for sex linkage in phenotypic variation
for these traits. Taken together, these ﬁndings suggest that
growth-related phenotypes in Turner syndrome are medi-
ated in part by one or more autosomal imprinted genes,
as well as by X-linked genes.
Alternative hypotheses for differences between
Xmat and Xpat Turner females
Most studies of phenotypic differences between Xmat and
Xpat Turner females have interpreted their results in
terms of hypothesized effects of one or more X-linked,
imprinted genes (e.g. Skuse et al. 1997; Sagi et al. 2007).
However there is, as yet, no conclusive evidence for the
presence of imprinted genes on the human X-chromo-
some, despite the discovery of several such genes in mice
(Davies et al. 2005; Raefski and O’Neill 2005) and the
inferred presence of X-linked imprinted genes in humans
from mapping of sex-differential effects on prenatal
lethality (Naumova et al. 1998; Green and Keverne 2000).
An alternative, though nonexclusive, hypothesis for dif-
ferences between Xmat and Xpat Turner females is con-
founding of parental origin of the X chromosome with
the form of the karyotype and the degree of mosaicism in
Turner syndrome, such that Xmat and Xpat females tend
to exhibit a different karyotype, a differing degree of
mosaicism, or both (Box 1). By this hypothesis, Turner
females with the Xmat intact, which tend to exhibit a
more male-typical Turner-syndrome phenotype for some
traits (Table 1), are presumed to have developed under a
lower degree of cryptic or documented mosaicism (which
leads to a relatively female-typical phenotype) (e.g. Henn
and Zang 1997; Haverkamp et al. 1999; Hanson et al.
2001; El-Mansoury et al. 2007), or under the inﬂuence of
speciﬁc karyotypes that produce a more female-typical
phenotype, such as karyotypes that lack Y-chromosome
material. Data on the frequency of different karyotypes
and mosaicism in Turner females with an intact Xmat
versus Xpat are now available from four studies, which
allows such alternative hypotheses to be evaluated.
First, in Bondy et al. (2007) (Table 1), 61 (46%) of
133 Xmat females were not pure 45,X karyotypes or
mosaics (for diverse karyotypes including 46,XX), com-
pared to 33 (66%) of 50 Xpat females (Fisher’s exact
test, P = 0.011). Considering monosomic and mosaic
females only, 44 (38%) of 116 Xmat females were mosaics,
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test, P = 0.0046). A lower level of mosaicism in Xmat
than Xpat Turner females is also suggested by some
hypotheses for the generation of Turner syndrome chro-
mosomal anomalies, which posit that deletions (and
some other alterations) of all or part of the X chromo-
some are relatively frequent in the rapidly replicating
paternal germ line (Kelly et al. 1992; Jacobs et al. 1997;
Uematsu et al. 2002), that mosaicism or a karyotype
other than 45,X early in development may be a prerequi-
site for viable embryonic development (Hecht and
Macfarlane 1969; Hook and Warburton 1983), and that
abnormal X chromosomes may be differentially lost in
development, such that all or most females karyotyped
after birth as 45,X are either cryptic mosaics (with a sec-
ond cell line present but undetected), or exhibited a
mosaic karyotype, or a partial second X, earlier in devel-
opment (Held et al. 1992; Amiel et al. 1996) (Fig. 1).
For example, Kelly et al. (1992) provide experimental
evidence that mosaicism may be present in fetuses with
Turner syndrome, but be lost prior to birth, resulting in
45,X. Mosaicism involving 45,X/46,XX can also be gener-
ated via postzygotic nondisjunction, a mechanism that
can also explain the presence of mosaicism of the form
45,X/47,XXX in some Turner females.
Second, Sagi et al. (2007) found that 83% (55 of 66) of
monosomic 45,X females were Xmat rather than Xpat,
whereas 36% (ﬁve of 14) females with the isodicentric
karyotype 46 XiXq bore Xmat as their intact X chromo-
some (Fisher’s exact test, P = 0.0007). These authors did
not ﬁnd signiﬁcant differences in any phenotypic trait
between females with monosomic 45,X versus isodicentric
46,XiXq karyotypes, but evidence for differences between
these two karyotypes has been reported in other studies
for IQ (Messina et al. 2007) and height (Cohen et al.
1995).
Third, the study population of Hamelin et al. (2006)
(Fig. 1) included 7 (20%) of 35 Xmat females that were
Box 1. Alternative, nonexclusive hypotheses for the presence of differences between Xmat and Xpat females that parallel the differences
between males and females.
(1) Genomic imprinting. For X-linked imprinted genes, gene dosages are expected to differ between males and females, with the nature of the
difference depending upon the direction of imprinting and whether or not the gene is X-inactivated (Skuse 1999). Males exclusively bear the
maternally inherited X, so Turner females with an intact maternally inherited X are expected to exhibit relatively male-typical phenotypes for traits
mediated by X-linked imprinted genes. By contrast, females bear one paternally inherited X, and one maternally inherited X.
(2) Mosaicism and karyotype. For X-linked genes that are not inactivated, males express one copy, and 46,XX females express two copies. To
the extent that human sexual dimorphism is mediated by dosages of such X-linked genes, Turner females are expected to exhibit some degree of
male-typical traits. Turner females with a monosomic 45,X karyotype are thus expected to bear traits relatively more typical of males than Turner
females with other karyotypes. To the extent that the 45,X karyotype differentially involves the maternally inherited X, due to the nature of the
cytogenetic mechanisms whereby it becomes the sole or primary cell line (e.g. Fig. 1), Turner females with an intact maternal X are expected to
be more likely to exhibit relatively male-typical traits, compared to Turner females with an intact paternal X. Females with a maternally inherited X
are also more likely to bear Y-chromosomal material, but there is no evidence that Y-linked genes mediate the phenotype in Turner syndrome
except in some cases of 45,X/46,XY mosaicism, which is rare.
Sperm with  
Xp deletion
Egg with  
normal X
Loss of X chromosomes  
with Xp deletion in fetal 
development
46,XdelX 
  zygote
45,X / 46,XdelX 
  mosaic fetus 
45,X neonate with 
 Turner syndrome 
  and maternal X
46,XdelX cell 
line lost
Figure 1 One scenario for the generation and development of
monosomy 45,X with the intact chromosome maternally inherited, in
Turner syndrome. This series of events is compatible with data show-
ing a high incidence of 45,X in aborted fetuses, which apparently
exhibited this karyotype at fertilization (Hook and Warburton 1983),
and with data showing changes in karyotype over time, with differen-
tial loss of abnormal X chromosomes in some cases (Held et al. 1992;
Kelly et al. 1992; Amiel et al. 1996). Turner females may also be born
with a mosaic karyotype, depending upon the rate of loss of the
abnormal X chromosome. Deletions of Xp, and some other cytoge-
netic changes involving the X, may be relatively more common in the
rapidly dividing paternal germ line (Uematsu et al. 2002). The 45,X
karyotype is much more common in females with a maternally inher-
ited X than with a paternally inherited X (Uematsu et al. 2002; Bondy
et al. 2007; Sagi et al. 2007).
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included), and 8 (42%) of 19 Xpat females mosaic or
otherwise not 45,X (Fisher’s exact test, P = 0.080). How-
ever, this marginally nonsigniﬁcant difference was due to
a signiﬁcantly higher incidence of the nonmosaic 46,XiXq
karyotype in Xpat females; when this karyotype category
is excluded, the frequency of mosaics is essentially the
same in both Xmat (15%) and Xpat (18%) females for
their sample.
Fourth, Uematsu et al. (2002), Table III) assembled
data from 21 earlier studies, and found that most (459,
75% of 614) pure 45,X females bore an X of maternal
origin, while the 46,XiXq karyotype was about equally
distributed between Xmat (n = 60) and Xpat (n = 71)
females. Thus, considering these two karyotypes, pure
45,X karyotypes were signiﬁcantly more frequent in Xmat
females (88%) than in Xpat females (69%) (Fisher’s exact
test, P < 0.001). These results are consistent with the data
from Sagi et al. 2007) described above, with data from
Hamelin et al. (2006) who found a higher incidence of
isodicentric chromosomes in Xpat females, and with the
results of Bondy et al. (2007) given that in their sample,
the karyotype 45,X/46,XiXq comprised 13% of the Xmat
females, but 26% of the Xpat females.
Uematsu et al. (2002) also showed that 19 of 20
females with Y-chromosome material bore an intact
maternal X, which is consistent with simple expectations
from Mendelian inheritance. Overall, Y-chromosomal
material has been reported in about 10–20% of Turner
syndrome cases (Gravholt et al. 2000; Hanson et al. 2001;
Alvarez-Nava et al. 2003). In 45,X/46,XY mosaics, the
phenotype can vary from Turner-like female, to interme-
diate in sexual development, to male, depending upon
the presence or absence of the male-determining SRY
gene and the degree of mosaicism (Robinson et al. 1999;
Telvi et al. 1999). However, in Turner syndrome cases,
the presence and form of Y material is apparently not
associated with phenotype (Telvi et al. 1999).
Taken together, these data indicate that parental origin
of the X chromosome can be confounded with karyotype
in three ways: (i) females with an isodicentric karyotype
(46,XiXq or 45,X/46,XiXq) are relatively more likely, or
similarly likely, to bear an intact paternal than maternal
X chromosome, (ii) Xmat females appear less likely than
Xpat females to exhibit mosaicism when karyotyped and
(iii) Xmat females are more likely than Xpat females to
bear Y-chromosomal material. Based on available evi-
dence from karyotype-phenotype correlations, the second
difference may parsimoniously account, at least in part,
for parallel patterns in phenotypic variation between
Xmat versus Xpat Turner females, compared to males
versus 46,XX females. However, it is important to note
that these parallel patterns are by no means consistently
supported for each phenotype examined, and that more
data are needed on mosaicism in relation to parental ori-
gin of the X for robust evaluation of this hypothesis.
Most generally, separating the confounded effects of
parental origin of the X, karyotype and mosaicism
requires ﬁne-scale genotype–phenotye correlations with
larger samples than have been used thus far in most stud-
ies. Similar considerations should also apply to Klinefelter
syndrome, for which phenotypic differences between
XmatXmatY and XmatXpatY males have been described
(Stemkens et al. 2006; Wikstro ¨m et al. 2006). Thus, about
8–20% of Klinefelter patients are 46,XY/47,XXY mosaics
with relatively moderate phenotypes (Ratcliffe et al. 1986;
Bojesen et al. 2003; Abdelmoula et al. 2004), and only
XmatXmatY males may develop as a result of postzygotic
errors in mitosis (Thomas and Hassold 2003). Future
studies of the causes of phenotypic variation among and
between individuals with different sex chromosome aneu-
ploidies might usefully focus on traits, such as ﬁngerprint
ridge counts (Penrose 1968) and enamel and dentin
thickness (Alvesalo 1997; La ¨hdesma ¨ki and Alvesalo 2006),
for which male–female differences appear to mirror dif-
ferences between Turner females and Klinefelter males,
and for which effects of parental origin of the X have yet
to be investigated.
Conclusions
The development of human sexual dimorphism is medi-
ated by four main causes: (i) hormonal differences that
follow from activation of the SRY male-determining
gene, (ii) other effects of genes on the Y, (iii) dosage
effects of the 15–20% of X-linked genes that are not
inactivated (Carrel and Willard 2005), and (iv) hypo-
thetically, by genes that are X-linked and imprinted
(Skuse 1999, 2000, 2005; Arnold et al. 2004; Davies and
Wilkinson 2006; Xu and Disteche 2006; Blecher and
Erickson 2007). I have shown in this paper that the
differences between Turner syndrome females with an
intact maternally inherited versus paternally inherited
X chromosome broadly parallel the differences between
females who are monosomic 45,X versus other karyo-
types, and the differences between normal XY males
and XX females. A simple explanation for these
patterns, which is supported by data showing relatively
severe and relatively male-typical phenotypes in pure
X monosomy, is that in Turner syndrome the mater-
nally inherited X is more-frequently monosomic than
the paternally inherited X. To the extent that noninacti-
vated X-linked genes, differentially expressed between
XY males and XX females, explain variation in Turner
syndrome phenotypes, they are also implicated in the
development and evolution of human sex differences;
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exist and inﬂuence Turner syndrome phenotypes, the
patterns described here would strongly implicate such
genes as an important mechanism of sexual differentia-
tion. Determining the roles of X-linked imprinting,
karyotype, and mosaicism in Turner syndrome may
thus help in deciphering not just the genetic aetiology
of this condition, but also the genetic and epigenetic
basis of human sexual dimorphism (Davies and Wilkin-
son 2006; Skuse 2006).
Acknowledgements
I am grateful to T. Day and four anonymous reviewers
for helpful comments, and I thank the Natural Sciences
and Engineering Research Council of Canada and the Kil-
lam Trust for support.
Literature cited
Abdallah, B. M., C. H. Jensen, G. Gutierrez, R. G. Q. Leslie,
T. G. Jensen, and M. Kassem. 2004. Regulation of human
skeletal stem cells differentiation by Dlk1/Pref-1. Journal of
Bone and Mineral Research 19:841–852.
Abdallah, B. M., P. Boissy, Q. Tan, J. Dahlgaard, G. A. Trau-
stadottir, K. Kupisiewicz, J. Laborda et al. 2007. dlk1/FA1
regulates the function of human bone marrow mesenchymal
stem cells by modulating gene expression of pro-inﬂamma-
tory cytokines and immune response-related factors. Journal
of Biological Chemistry 282:7339–7351.
Abdelmoula, N. B., A. Amouri, M. Portnoi, A. Saad, T. Bou-
dawara, M. N. Mhiri, A. Bahloul, and T. Rebai. 2004. Cyto-
genetics and ﬂuorescence in situ hybridization assessment of
sex-chromosome mosaicism in Klinefelter’s syndrome.
Annales De Ge ´ne ´tique 47:163–175.
Alvarez-Nava, F., M. Soto, M. A. Sa ´nchez, E. Ferna ´ndez, and
R. Lanes. 2003. Molecular analysis in Turner syndrome.
Journal of Pediatrics 142:336–340.
Alvesalo, L. 1997. Sex chromosomes and human growth. A
dental approach. Human Genetics 101:1–5.
Amiel, A., D. Kidron, I. Kedar, E. Gaber, O. Reish, and M.
D. Fejgin. 1996. Are all phenotypically-normal Turner
syndrome fetuses mosaics? Prenatal Diagnosis 16:791–
795.
Ansell, P. J., Y. Zhou, B. Schjeide, A. Kerner, J. Zhao, X.
Zhang, and A. Klibanski. 2007. Regulation of growth hor-
mone expression by Delta-like protein 1 (Dlk1). Molecular
and Cellular Endocrinology 271:55–63.
Arnold, A. P., J. Xu, W. Grisham, X. Chen, Y. Kim, and Y.
Itoh. 2004. Minireview: sex chromosomes and brain sexual
differentiation. Endocrinology 145:1057–1062.
Baron-Cohen, S. 2003. The Essential Difference: The Truth
About the Male and Female Brain. Basic Books, New York.
Barrena ¨s, M. L., O. Nyle ´n, and C. Hanson. 1999. The inﬂuence
of karyotype on the auricle, otitis media and hearing in
Turner syndrome. Hearing Research 138:163–170.
Barrena ¨s, M., K. Landin-Wilhelmsen, and C. Hanson. 2000.
Ear and hearing in relation to genotype and growth in
Turner syndrome. Hearing Research 144:21–28.
Berg, J. S., N. Brunetti-Pierri, S. U. Peters, S. L. Kang, C. Fong,
J. Salamone, D. Freedenberg et al. 2007. Speech delay and
autism spectrum behaviors are frequently associated with
duplication of the 7q11.23 Williams-Beuren syndrome
region. Genetics in Medicine 9:427–441.
Bishop, D. V., E. Canning, K. Elgar, E. Morris, P. A. Jacobs,
and D. H. Skuse. 2000. Distinctive patterns of memory
function in subgroups of females with Turner syndrome:
evidence for imprinted loci on the X-chromosome affecting
neurodevelopment. Neuropsychologia 38:712–721.
Blecher, S. R., and R. P. Erickson. 2007. Genetics of sexual
development: a new paradigm. American Journal of Medical
Genetics. Part A. 143:3054–3068.
Bojesen, A., S. Juul, and C. H. Gravholt. 2003. Prenatal and
postnatal prevalence of Klinefelter syndrome: a national reg-
istry study. Journal of Clinical Endocrinology and Metabolism
88:622–626.
Bondy, C. A. 2006. Turner’s syndrome and X chromosome-
based differences in disease susceptibility. Gender Medicine
3:18–30.
Bondy, C. A., L. A. Matura, N. Wooten, J. Troendle, A. R.
Zinn, and V. K. Bakalov. 2007. The physical phenotype of
girls and women with Turner syndrome is not X-imprinted.
Human Genetics 121:469–474.
Brock, J. (2007) Language abilities in Williams syndrome: a
critical review. Development and Psychopathology 19:97–127.
Brown, W. E., S. R. Kesler, S. Eliez, I. S. Warsofsky, M. Haber-
echt, A. Patwardhan, J. L. Ross et al. 2002. Brain develop-
ment in Turner syndrome: a magnetic resonance imaging
study. Psychiatry Research 116:187–196.
Burman, P., A. G. Johansson, A. Siegbahn, B. Vessby, and
F. A. Karlsson. 1997. Growth hormone (GH)-deﬁcient
men are more responsive to GH replacement therapy than
women. Journal of Clinical Endocrinology and Metabolism
82:550–555.
Carrel, L., and H. F. Willard. 2005. X-inactivation proﬁle
reveals extensive variability in X-linked gene expression in
females. Nature 434:400–404.
Chen, X., P. S. Sachdev, W. Wen, and K. J. Anstey. 2007. Sex
differences in regional gray matter in healthy individuals
aged 44–48 years: a voxel-based morphometric study. Neuro-
Image 36:691–699.
Chu, C. E., M. D. Donaldson, C. J. Kelnar, P. J. Smail, S. A.
Greene, W. F. Paterson, and J. M. Connor. 1994. Possible
role of imprinting in the Turner phenotype. Journal of Medi-
cal Genetics 31:840–842.
Cohen, A., R. Kauli, A. Pertzelan, A. Lavagetto, Y. Roitmano,
C. Romano, and Z. Laron. 1995. Final height of girls with
Crespi Turner syndrome and sexual dimorphism
ª 2008 The Author
Journal compilation ª 2008 Blackwell Publishing Ltd 1 (2008) 449–461 457Turner’s syndrome: correlation with karyotype and parental
height. Acta Paediatrica 84:550–554.
Crespi, B., and C. Badcock. 2008. Psychosis and autism as
diametrical disorders of the social brain. Behavioral and
Brain Sciences (in press).
Cutter, W. J., E. M. Daly, D. M. Robertson, X. A. Chitnis,
T. A. van Amelsvoort, A. Simmons, V. W. Ng et al. 2006.
Inﬂuence of X chromosome and hormones on human brain
development: a magnetic resonance imaging and proton
magnetic resonance spectroscopy study of Turner syndrome.
Biological Psychiatry 59:273–283.
Davies, W., and L. S. Wilkinson. 2006. It is not all hormones:
alternative explanations for sexual differentiation of the
brain. Brain Research 1126:36–45.
Davies, W., A. Isles, R. Smith, D. Karunadasa, D. Burrmann,
T. Humby, O. Ojarikre et al. 2005. Xlr3b is a new imprinted
candidate for X-linked parent-of-origin effects on cognitive
function in mice. Nature Genetics 37:625–629.
Davies, W., A. R. Isles, P. S. Burgoyne, and L. S. Wilkinson.
2006. X-linked imprinting: effects on brain and behaviour.
BioEssays 28:35–44.
Devi, A. S., D. A. Metzger, A. A. Luciano, and P. A. Benn.
1998. 45,X/46,XX mosaicism in patients with idiopathic pre-
mature ovarian failure. Fertility and Sterility 70:89–93.
El-Mansoury, M., M. Barrena ¨s, I. Bryman, C. Hanson, C. Lars-
son, L. Wilhelmsen, and K. Landin-Wilhelmsen. 2007. Chro-
mosomal mosaicism mitigates stigmata and cardiovascular
risk factors in Turner syndrome. Clinical Endocrinology
66:744–751.
Feinstein, C. and S. Singh. 2007. Social phenotypes in neuro-
genetic syndromes. Child and Addescent Psychiatry Clinics of
North America 16:631–647.
Ferna ´ndez-Garcı ´a, R., S. Garcı ´a-Doval, S. Costoya, and E. Pa ´s-
aro. 2000. Analysis of sex chromosome aneuploidy in 41
patients with Turner syndrome: a study of ‘hidden’ mosai-
cism. Clinical Genetics 58:201–208.
Freedman, D. S., B. A. Bowman, J. D. Otvos, S. R. Srinivasan,
and G. S. Berenson. 2000. Levels and correlates of LDL and
VLDL particle sizes among children: the Bogalusa heart
study. Atherosclerosis 152:441–449.
Freedman, D. S., J. D. Otvos, E. J. Jeyarajah, I. Shalaurova, L. A.
Cupples, H. Parise, R. B. D’Agostino, P. W. Wilson and
E. J. Schaefer. 2004. Sex and age differences in lipoprotein
subclasses measured by nuclear magnetic resonance spectro-
scopy: the Framington Study. Clinical Chemistry 50:1189–
1200.
Geary, D. C. 1998. Male, Female: The Evolution of Human Sex
Differences. American Psychological Association, Washing-
ton, DC.
Geodakian, V. A., and A. L. Sherman. 1970. Congenital heart
disease and sex. Eksperimental’Naia Khirurgiia i Anes-
teziologiia 15:18–23.
Geodakian, V. A., and A. L. Sherman. 1971. Relation of
congenital anomalies to sex. Zhurnal Obshche  Biologii
32:417–424.
Good, C. D., I. Johnsrude, J. Ashburner, R. N. Henson, K. J.
Friston, and R. S. Frackowiak. 2001. Cerebral asymmetry
and the effects of sex and handedness on brain structure: a
voxel-based morphometric analysis of 465 normal adult
human brains. NeuroImage 14:685–700.
Good, C. D., K. Lawrence, N. S. Thomas, C. J. Price, J. Ash-
burner, K. J. Friston, R. S. J. Frackowiak et al. 2003. Dosage-
sensitive X-linked locus inﬂuences the development of
amygdala and orbitofrontal cortex, and fear recognition in
humans. Brain 126:2431–2446.
Gøtzsche, C. O., B. Krag-Olsen, J. Nielsen, K. E. Sørensen,
and B. O. Kristensen. 1994. Prevalence of cardiovascular
malformations and association with karyotypes in
Turner’s syndrome. Archives of Disease in Childhood
71:433–436.
Gravholt, C. H., J. Fedder, R. W. Naeraa, and J. Mu ¨ller. 2000.
Occurrence of gonadoblastoma in females with Turner
syndrome and Y chromosome material: a population study.
The Journal of Clinical Endocrinology and Metabolism
85:3199–3202.
Gravholt, C. H., B. E. Hjerrild, R. W. Naeraa, F. Engbaek,
L. Mosekilde, and J. S. Christiansen. 2005. Effect of growth
hormone and 17beta-oestradiol treatment on metabolism
and body composition in girls with Turner syndrome.
Clinical Endocrinology 62:616–622.
Green, R., and E. B. Keverne. 2000. The disparate maternal
aunt-uncle ratio in male transsexuals: an explanation invok-
ing genomic imprinting. Journal of Theoretical Biology
202:55–63.
Haig, D., and R. Wharton. 2003. Prader-Willi syndrome and
the evolution of human childhood. American Journal of
Human Biology 15:320–329.
Hamelin, C. E., G. Anglin, C. A. Quigley, and C. L. Deal.
2006. Genomic imprinting in Turner syndrome: effects on
response to growth hormone and on risk of sensorineural
hearing loss. Journal of Clinical Endocrinology and Metabo-
lism 91:3002–3010.
Hanson, L., I. Bryman, M. L. Barrena ¨s, P. O. Janson,
J. Wahlstro ¨m, K. Albertsson-Wikland, and C. Hanson. 2001.
Genetic analysis of mosaicism in 53 women with Turner
syndrome. Hereditas 134:153–159.
Haverkamp, F., J. Wo ¨lﬂe, K. Zerres, O. Butenandt, P. Amendt,
B. P. Hauffa, E. Weimann et al. 1999. Growth retardation in
Turner syndrome: aneuploidy, rather than speciﬁc gene loss,
may explain growth failure. Journal of Clinical Endocrinology
and Metabolism 84:4578–4582.
Hecht, F., and J. P. Macfarlane. 1969. Mosaicism in Turner’s
syndrome reﬂects the lethality of XO. Lancet 2:1197–1198.
Held, K. R., S. Kerber, E. Kaminsky, S. Singh, P. Goetz, E.
Seemanova, and H. W. Goedde. 1992. Mosaicism in
45,X Turner syndrome: does survival in early pregnancy
depend on the presence of two sex chromosomes? Human
Genetics 88:288–294.
Henn, W., and K. D. Zang. 1997. Mosaicism in Turner’s syn-
drome. Nature 390:569–569.
Turner syndrome and sexual dimorphism Crespi
ª 2008 The Author
458 Journal compilation ª 2008 Blackwell Publishing Ltd 1 (2008) 449–461Henry, K. R.. 2004. Males lose hearing earlier in mouse models
of late-onset age-related hearing loss; females lose hearing
earlier in mouse models of early-onset hearing loss. Hearing
Research 190:141–148.
Hermens, D. F., M. R. Kohn, S. D. Clarke, E. Gordon,
and L. M. Williams. 2005. Sex differences in adolescent
ADHD: ﬁndings from concurrent EEG and EDA. Clinical
Neurophysiology 116:1455–1463.
Hook, E. B., and D. Warburton. 1983. The distribution of
chromosomal genotypes associated with Turner’s syndrome:
livebirth prevalence rates and evidence for diminished fetal
mortality and severity in genotypes associated with structural
X abnormalities or mosaicism. Human Genetics 64:24–27.
Iwasa, Y., and A. Pomiankowski. 1999. Sex speciﬁc X chromo-
some expression caused by genomic imprinting. Journal of
Theoretical Biology 197:487–495.
Jacobs, P., P. Dalton, R. James, K. Mosse, M. Power, D. Rob-
inson, and D. Skuse. 1997. Turner syndrome: a cytogenetic
and molecular study. Annals of Human Genetics 61:471–483.
Jolliffe, C. J., and I. Janssen. 2006. Distribution of lipoproteins
by age and gender in adolescents. Circulation 114:1056–
1062.
Kelly, T. E., J. E. Ferguson, and W. Golden. 1992. Survival of
fetuses with 45,X: an instructive case and an hypothesis.
American Journal of Medical Genetics 42:825–826.
Kesler, S. R.. 2007. Turner syndrome. Child and Adolescent
Psychiatric Clinics of North America 16:709–722.
Kesler, S. R., C. M. Blasey, W. E. Brown, J. Yankowitz,
S. M. Zeng, B. G. Bender, and A. L. Reiss. 2003. Effects of
X-monosomy and X-linked imprinting on superior temporal
gyrus morphology in Turner syndrome. Biological Psychiatry
54:636–646.
Kesler, S. R., A. Garrett, B. Bender, J. Yankowitz, S. M. Zeng,
and A. L. Reiss. 2004. Amygdala and hippocampal volumes
in Turner syndrome: a high-resolution MRI study of
X-monosomy. Neuropsychologia 42:1971–1978.
King, K. A., T. Makishima, C. K. Zalewski, V. K. Bakalov,
A. J. Grifﬁth, C. A. Bondy, and C. C. Brewer. 2007. Analysis
of auditory phenotype and karyotype in 200 females with
Turner syndrome. Ear and Hearing 28:831–841.
Kochi, C., C. A. Longui, S. H. V. Lemos-Marini, G. Guerra-
Junior, M. B. Melo, L. E. P. Calliari, and O. Monte. 2007.
The inﬂuence of parental origin of X chromosome genes on
the stature of patients with 45 X Turner syndrome. Genetics
and Molecular Research 6:1–7.
Kotzot, D. 2004. Maternal uniparental disomy 14 dissection of
the phenotype with respect to rare autosomal recessively
inherited traits, trisomy mosaicism, and genomic imprinting.
Annales De Ge ´ne ´tique 47:251–260.
La ¨hdesma ¨ki, R., and L. Alvesalo. 2006. Root growth in the
permanent teeth of 45,X/46,XX females. European Journal
of Orthodontics 28:339–344.
Lary, J. M., and L. J. Paulozzi. 2001. Sex differences in the
prevalence of human birth defects: a population-based study.
Teratology 64:237–251.
Leppig, K. A., and C. M. Disteche. 2001. Ring X and other
structural X chromosome abnormalities: X inactivation and
phenotype. Seminars in Reproductive Medicine 19:147–157.
Lorda-Sanchez, I., F. Binkert, M. Maechler, and A. Schinzel.
1992. Molecular study of 45,X conceptuses: correlation with
clinical ﬁndings. American Journal of Medical Genetics
42:487–490.
Loschiavo, M., Q. K. Nguyen, A. R. Duselis, and P. B. Vrana.
2007. Mapping and identiﬁcation of candidate loci responsi-
ble for Peromyscus hybrid overgrowth. Mammalian Genome
18:75–85.
Lynn, P. M. Y., and W. Davies. 2007. The 39,XO mouse
as a model for the neurobiology of Turner syndrome and
sex-biased neuropsychiatric disorders. Behavioural Brain
Research 179:173–182.
Mathur, A., L. Stekol, D. Schatz, N. K. MacLaren, M. L. Scott,
and B. Lippe. 1991. The parental origin of the single
X chromosome in Turner syndrome: lack of correlation with
parental age or clinical phenotype. American Journal of
Human Genetics 48:682–686.
Messina, M. F., G. Zirilli, R. Civa, I. Rulli, G. Salzano, T. Aver-
sa, and M. Valenzise. 2007. Neurocognitive proﬁle in Turn-
er’s syndrome is not affected by growth impairment. Journal
of Pediatric Endocrinology & Metabolism 20:677–684.
Meyer-Lindenberg, A., C. B. Mervis, and K. F. Berman. 2006.
Neural mechanisms in Williams syndrome: a unique
window to genetic inﬂuences on cognition and behaviour.
Nature Reviews Neuroscience 7:380–393.
Migeon, B. R., P. Jeppesen, B. S. Torchia, S. Fu, M. A. Dunn,
J. Axelman, B. J. Schmeckpeper et al. 1996. Lack of X inacti-
vation associated with maternal X isodisomy: evidence for a
counting mechanism prior to X inactivation during human
embryogenesis. American Journal of Human Genetics 58:161–
170.
Mills, W., and T. Moore. 2006. Evolution of mammalian
X chromosome-linked imprinting. Cytogenetic and Genome
Research 113:336–344.
Money, J. 1993. Speciﬁc neuro-cognitive impairments associ-
ated with Turner (45,X) and Klinefelter (47,XXY) syn-
dromes: a review. Social Biology 40:147–151.
Morimoto, N., T. Tanaka, H. Taiji, R. Horikawa, Y. Naiki, Y.
Morimoto, and N. Kawashiro. 2006. Hearing loss in Turner
syndrome. Journal of Pediatrics 149:697–701.
Mukhopadhyay, N., and D. E. Weeks. 2003. Linkage analysis
of adult height with parent-of-origin effects in the Framing-
ham Heart Study. BMC Genetics 4(Suppl. 1):S76.
Murphy, D. G., C. DeCarli, E. Daly, J. V. Haxby, G. Allen, B.
J. White, A. R. McIntosh et al. 1993. X-chromosome effects
on female brain: a magnetic resonance imaging study of
Turner’s syndrome. Lancet 342:1197–1200.
Murphy, D. G., G. Allen, J. V. Haxby, K. A. Largay, E. Daly,
B. J. White, C. M. Powell, and M. B. Schapiro. 1994. The
effects of sex steroids, and the X chromosome, on female
brain function: a study of the neuropsychology of adult
Turner syndrome. Neuropsychologia 32:1309–1323.
Crespi Turner syndrome and sexual dimorphism
ª 2008 The Author
Journal compilation ª 2008 Blackwell Publishing Ltd 1 (2008) 449–461 459Murphy, D. G., M. J. Mentis, P. Pietrini, C. Grady, E. Daly, J.
V. Haxby, M. De La Granja et al. 1997. A PET
study of Turner’s syndrome: effects of sex steroids and the
X chromosome on brain. Biological Psychiatry 41:285–298.
Naumova, A. K., L. Olien, L. M. Bird, M. Smith, A. E. Verner,
M. Leppert, K. Morgan, and C. Sapienza. 1998. Genetic
mapping of X-linked loci involved in skewing of X chromo-
some inactivation in the human. European Journal of Human
Genetics 6:552–562.
Nielsen, J.. 1976. Cell selection in vivo in normal/aneuploid
chromosome abnormalities. Human Genetics 32:203–206.
Nielsen, R., C. Bustamante, A. G. Clark, S. Glanowski, T. B.
Sackton, M. J. Hubisz, A. Fledel-Alon et al. 2005. A scan for
positively selected genes in the genomes of humans and
chimpanzees. PLoS Biology 3:e170.
Oliver, C., K. Horsler, K. Berg, G. Bellamy, K. Dick, and E.
Grifﬁths. 2007. Genomic imprinting and the expression of
affect in Angelman syndrome: what’s in the smile? Journal of
Child Psychology and Psychiatry, and Allied Disciplines
48:571–579.
Pan, L., C. Ober, and M. Abney. 2007. Heritability estimation
of sex-speciﬁc effects on human quantitative traits. Genetic
Epidemiology 31:338–347.
Penrose, L. S.. 1968. Medical signiﬁcance of ﬁnger-prints and
related phenomena. British Medical Journal 2:321–325.
Prandstraller, D., L. Mazzanti, F. M. Picchio, C. Magnani, R.
Bergamaschi, A. Perri, E. Tsingos, and E. Cacciari. 1999.
Turner’s syndrome: cardiologic proﬁle according to the
different chromosomal patterns and long-term clinical
follow-Up of 136 nonpreselected patients. Pediatric
Cardiology 20:108–112.
Raefski, A. S., and M. J. O’Neill. 2005. Identiﬁcation of a clus-
ter of X-linked imprinted genes in mice. Nature Genetics
37:620–624.
Ratcliffe, S. G., L. Murray, and P. Teague. 1986. Edinburgh
study of growth and development of children with sex
chromosome abnormalities. III. Birth Defects Original Article
Series 22:73–118.
Reish, O., R. Gal, E. Gaber, C. Sher, T. Bistritzer, and A.
Amiel. 2002. Asynchronous replication of biallelically
expressed loci: a new phenomenon in Turner syndrome.
Genetics in Medicine 4:439–443.
Robinson, D. O., P. Dalton, P. A. Jacobs, K. Mosse,
M. M. Power, D. H. Skuse, and J. A. Crolla. 1999. A molec-
ular and FISH analysis of structurally abnormal Y chromo-
somes in patients with Turner syndrome. Journal of Medical
Genetics 36:279–284.
Ross, J. L. 2005. Effects of growth hormone on cognitive func-
tion. Hormone Research 64(Suppl. 3):89–94.
Ross, J. L., J. G. Hall, and E. G. Pfendner. 1991. The contribu-
tion of imprinting to the phenotype in Turner syndrome.
American Journal of Human Genetics 49:s19.
Russell, H. F., D. Wallis, M. M. M. Mazzocco, T. Moshang, E.
Zackai, A. R. Zinn, J. L. Ross, and M. Muenke. 2006.
Increased prevalence of ADHD in Turner syndrome with no
evidence of imprinting effects. Journal of Pediatric Psychology
31:945–955.
Sagi, L., N. Zuckerman-Levin, A. Gawlik, L. Ghizzoni, A. Buy-
ukgebiz, Y. Rakover, T. Bistritzer et al. 2007. Clinical signiﬁ-
cance of the parental origin of the X chromosome in turner
syndrome. Journal of Clinical Endocrinology and Metabolism
92:846–852.
Salerno, M. C., and J. C. Job. 1987. Height in Turner’s syn-
drome: correlation with parents’ height. Archives Franc ¸aises
de Pe ´diatrie 44:863–865.
Shaw, G. M., S. L. Carmichael, Z. Kaidarova, and J. A. Harris.
2003. Differential risks to males and females for congenital
malformations among 2.5 million California births, 1989–
1997. Birth Defects Research. Part A, Clinical and Molecular
Teratology 67:953–958.
Simpson, J. L., F. de la Cruz, R. S. Swerdloff, C. Samango-
Sprouse, N. E. Skakkebaek, J. M. Graham, T. Hassold et al.
2003. Klinefelter syndrome: expanding the phenotype and
identifying new research directions. Genetics in Medicine
5:460–468.
Skuse, D. H. 1999. Genomic imprinting of the X chromo-
some: a novel mechanism for the evolution of sexual
dimorphism. Journal of Laboratory and Clinical Medicine
133:23–32.
Skuse, D. H. 2000. Imprinting, the X-chromosome, and the
male brain: explaining sex differences in the liability to
autism. Pediatric Research 47:9–16.
Skuse, D. H. 2005. X-linked genes and mental functioning.
Human Molecular Genetics 14 (Spec No. 1):r27–r32.
Skuse, D. H. 2006. Sexual dimorphism in cognition and
behaviour: the role of X-linked genes. European Journal of
Endocrinology 155(Suppl. 1):s99–s106.
Skuse, D. H., R. S. James, D. V. Bishop, B. Coppin, P.
Dalton, G. Aamodt-Leeper, M. Bacarese-Hamilton et al.
1997. Evidence from Turner’s syndrome of an imprinted
X-linked locus affecting cognitive function. Nature
387:705–708.
Stemkens, D., T. Roza, L. Verrij, H. Swaab, M. K. van
Werkhoven, B. Z. Alizadeh, R. J. Sinke, and J. C. Giltay.
2006. Is there an inﬂuence of X-chromosomal imprinting
on the phenotype in Klinefelter syndrome? A clinical and
molecular genetic study of 61 cases. Clinical Genetics
70:43–48.
Sybert, V. P., and E. McCauley. 2004. Turner’s syndrome. New
England Journal of Medicine 351:1227–1238.
Tassabehji, M. 2003. Williams-Beuren syndrome: a challenge
for genotype-phenotype correlations. Human Molecular
Genetics 12 (Spec No. 2):R229–R237.
Telvi, L., A. Lebbar, O. Del Pino, J. P. Barbet, and J. L.
Chaussain. 1999. 45,X/46,XY mosaicism: report of 27 cases.
Pediatrics 104:304–308.
Temple, C. M., and R. A. Carney. 1993. Intellectual function-
ing of children with Turner syndrome: a comparison of
behavioural phenotypes. Developmental Medicine and Child
Neurology 35:691–698.
Turner syndrome and sexual dimorphism Crespi
ª 2008 The Author
460 Journal compilation ª 2008 Blackwell Publishing Ltd 1 (2008) 449–461Temple, I. K., V. Shrubb, M. Lever, H. Bullman, and D. J. G.
Mackay. 2007. Isolated imprinting mutation of the DLK1/
GTL2 locus associated with a clinical presentation of mater-
nal uniparental disomy of chromosome 14. Journal of
Medical Genetics 44:637–640.
Thangavel, C., and B. H. Shapiro. 2007. A molecular basis for
the sexually dimorphic response to growth hormone. Endo-
crinology 148:2894–2903.
Thomas, N. S., and T. J. Hassold. 2003. Aberrant recombina-
tion and the origin of Klinefelter syndrome. Human Repro-
duction Update 9:309–317.
Tsezou, A., C. Hadjiathanasiou, D. Gourgiotis, A. Galla, E.
Kavazarakis, A. Pasparaki, M. Kapsetaki et al. 1999. Molecu-
lar genetics of Turner syndrome: correlation with clinical
phenotype and response to growth hormone therapy. Clini-
cal Genetics 56:441–446.
Uematsu, A., T. Yorifuji, J. Muroi, M. Kawai, M. Mamada,
M. Kaji, C. Yamanaka et al. 2002. Parental origin of normal
X chromosomes in Turner syndrome patients with various
karyotypes: implications for the mechanism leading to gen-
eration of a 45,X karyotype. American Journal of Medical
Genetics 111:134–139.
Vallender, E. J., and B. T. Lahn. 2004. How mammalian sex
chromosomes acquired their peculiar gene content. BioEssays
26:159–169.
Van, P. L., V. K. Bakalov, and C. A. Bondy. 2006a. Monosomy
for the X-chromosome is associated with an atherogenic
lipid proﬁle. Journal of Clinical Endocrinology and Metabo-
lism 91:2867–2870.
Van, P. L., V. K. Bakalov, A. R. Zinn, and C. A. Bondy.
2006b. Maternal X chromosome, visceral adiposity, and lipid
proﬁle. Journal of the American Medical Association
295:1373–1374.
Vawter, M. P., P. D. Harvey, and L. E. Delisi. 2007. Dysregula-
tion of X-linked gene expression in Klinefelter’s syndrome
and association with verbal cognition. American Journal of
Medical Genetics. Part B. Neuropsychiatric Genetics
144B:728–734.
Vrana, P. B., J. A. Fossella, P. Matteson, T. del Rio, M. J.
O’Neill, and S. M. Tilghman. 2000. Genetic and epigenetic
incompatibilities underlie hybrid dysgenesis in Peromyscus.
Nature Genetics 25:120–124.
Wikstro ¨m, A. M., J. N. Painter, T. Raivio, K. Aittoma ¨ki, and
L. Dunkel. 2006. Genetic features of the X chromosome
affect pubertal development and testicular degeneration in
adolescent boys with Klinefelter syndrome. Clinical Endocri-
nology 65:92–97.
Wilke, M., I. Kra ¨geloh-Mann, and S. K. Holland. 2007. Global
and local development of gray and white matter volume in
normal children and adolescents. Experimental Brain
Research 178:296–307.
Wolff, D. J., S. Schwartz, and L. Carrel. 2000. Molecular deter-
mination of X inactivation pattern correlates with phenotype
in women with a structurally abnormal X chromosome.
Genetics in Medicine 2:136–141.
Xu, J., and C. M. Disteche. 2006. Sex differences in brain
expression of X- and Y-linked genes. Brain Research
1126:50–55.
Crespi Turner syndrome and sexual dimorphism
ª 2008 The Author
Journal compilation ª 2008 Blackwell Publishing Ltd 1 (2008) 449–461 461